0
Article |

Clinical Experience With Cendehill Rubella Vaccine in Mature Women

John D. Farquhar, MD; Jorge E. Corretjer, MD
Am J Dis Child. 1969;118(2):266-268. doi:10.1001/archpedi.1969.02100040268023.
Text Size: A A A
Published online

RECENTLY reported experience1 with live attenuated rubella vaccines suggested that all of the vaccines currently under investigation elicit approximately the same hemagglutination inhibiting (HI) antibody response and none produce any significant clinical reactions in children. However, when used in rubella-susceptible mature women, the high risk population for rubella, the vaccines appeared to differ in the incidence and degree of associated side effects.2-4 The HPV-77 rubella vaccine and its modifications grown in duck embryo and dog kidney cultures caused the signs and symptoms of a natural rubella infection in a high percentage of mature women vaccinees. The most troublesome of these side effects was arthralgia or arthritis.5 In contrast, the Cendehill rubella vaccine seemed to cause a minimum of side effects in adult vaccinees.2-6

Our present studies were undertaken to determine the incidence and severity of side effects with the Cendehill rubella vaccine in a significant

Sign In to Access Full Content

Don't have Access?

Register and get free email Table of Contents alerts, saved searches, PowerPoint downloads, CME quizzes, and more

Subscribe for full-text access to content from 1998 forward and a host of useful features

Activate your current subscription (AMA members and current subscribers)

Purchase Online Access to this article for 24 hours

Figures

Tables

Interactive Graphics

Video

Country-Specific Mortality and Growth Failure in Infancy and Yound Children and Association With Material Stature

Use interactive graphics and maps to view and sort country-specific infant and early dhildhood mortality and growth failure data and their association with maternal

References

Correspondence

CME
Accreditation Information
The American Medical Association is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. The AMA designates this journal-based CME activity for a maximum of 1 AMA PRA Category 1 CreditTM per course. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Physicians who complete the CME course and score at least 80% correct on the quiz are eligible for AMA PRA Category 1 CreditTM.
Note: You must get at least of the answers correct to pass this quiz.
You have not filled in all the answers to complete this quiz
The following questions were not answered:
Sorry, you have unsuccessfully completed this CME quiz with a score of
The following questions were not answered correctly:
Commitment to Change (optional):
Indicate what change(s) you will implement in your practice, if any, based on this CME course.
Your quiz results:
The filled radio buttons indicate your responses. The preferred responses are highlighted
For CME Course: A Proposed Model for Initial Assessment and Management of Acute Heart Failure Syndromes
Indicate what changes(s) you will implement in your practice, if any, based on this CME course.
NOTE:
Citing articles are presented as examples only. In non-demo SCM6 implementation, integration with CrossRef’s “Cited By” API will populate this tab (http://www.crossref.org/citedby.html).
Submit a Comment

Some tools below are only available to our subscribers or users with an online account.

Sign In to Access Full Content

Related Content

Customize your page view by dragging & repositioning the boxes below.

Jobs